What is Tishcon?
Founded in 1976 and headquartered in Westbury, New York, Tishcon has established itself as a cornerstone manufacturer within the pharmaceutical industry. The company specializes in the complex processes required for high-quality drug manufacturing, serving as a critical link in the healthcare supply chain. With decades of experience, Tishcon maintains a robust infrastructure designed to meet stringent regulatory standards and the evolving needs of the global pharmaceutical market. Its longevity is a testament to its operational resilience and its ability to adapt to the shifting demands of medical manufacturing, from formulation to final product delivery.
How much funding has Tishcon raised?
Tishcon has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
Key Investors in Tishcon
PPP
Public-Private Partnership
What's next for Tishcon?
Looking ahead, the strategic deployment of this capital is expected to focus on enhancing manufacturing efficiency and expanding production capacity to meet rising enterprise-level demand. As the pharmaceutical sector continues to prioritize supply chain security and domestic manufacturing capabilities, Tishcon is well-positioned to leverage its historical expertise to capture additional market share. The company's focus will likely remain on scaling its core competencies while maintaining the rigorous quality control protocols that have defined its four-decade tenure. By integrating advanced manufacturing technologies and optimizing its existing facilities, Tishcon aims to solidify its role as a primary manufacturer for pharmaceutical partners seeking stability and scale in an increasingly volatile global market.
See full Tishcon company page
